Selected research
Industry Research
Formula DHA Industry Research Report 2026
Market perspective
The global Formula DHA market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Formula DHA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Formula DHA is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Formula DHA is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Formula DHA include DSM, Roquette, ADM, Corbion, Lonza Group, CABIO, Fuxing, Runke and Cellana, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Formula DHA market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Formula DHA Market by Company
DSM
Roquette
ADM
Corbion
Lonza Group
CABIO
Fuxing
Runke
Cellana
JC Biotech
Yuexiang
FEMICO
Huison
Qingdao Keyuan
Formula DHA Segment by Type
Natural
Concentrated
Formula DHA Segment by Application
Adult Formula
Infant Formula
Formula DHA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formula DHA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Formula DHA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formula DHA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Formula DHA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Formula DHA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Formula DHA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural
- Concentrated
Applications
- Adult Formula
- Infant Formula
Companies covered
- DSM
- Roquette
- ADM
- Corbion
- Lonza Group
- CABIO
- Fuxing
- Runke
- Cellana
- JC Biotech
- Yuexiang
- FEMICO
- Huison
- Qingdao Keyuan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Formula DHA Market Size (2021-2032)
- 2.2.2 Global Formula DHA Sales (2021-2032)
- 2.2.3 Global Formula DHA Market Average Price (2021-2032)
- 2.3 Formula DHA by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Natural
- 2.3.3 Concentrated
- 2.4 Formula DHA by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult Formula
- 2.4.3 Infant Formula
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Formula DHA Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Formula DHA Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Formula DHA Revenue of Manufacturers (2021-2026)
- 3.4 Global Formula DHA Average Price by Manufacturers (2021-2026)
- 3.5 Global Formula DHA Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Formula DHA, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Formula DHA, Product Type & Application
- 3.8 Global Manufacturers of Formula DHA, Established Date
- 3.9 Global Formula DHA Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DSM
- 4.1.1 DSM Company Information
- 4.1.2 DSM Business Overview
- 4.1.3 DSM Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DSM Formula DHA Product Portfolio
- 4.1.5 DSM Recent Developments
- 4.2 Roquette
- 4.2.1 Roquette Company Information
- 4.2.2 Roquette Business Overview
- 4.2.3 Roquette Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roquette Formula DHA Product Portfolio
- 4.2.5 Roquette Recent Developments
- 4.3 ADM
- 4.3.1 ADM Company Information
- 4.3.2 ADM Business Overview
- 4.3.3 ADM Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ADM Formula DHA Product Portfolio
- 4.3.5 ADM Recent Developments
- 4.4 Corbion
- 4.4.1 Corbion Company Information
- 4.4.2 Corbion Business Overview
- 4.4.3 Corbion Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Corbion Formula DHA Product Portfolio
- 4.4.5 Corbion Recent Developments
- 4.5 Lonza Group
- 4.5.1 Lonza Group Company Information
- 4.5.2 Lonza Group Business Overview
- 4.5.3 Lonza Group Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lonza Group Formula DHA Product Portfolio
- 4.5.5 Lonza Group Recent Developments
- 4.6 CABIO
- 4.6.1 CABIO Company Information
- 4.6.2 CABIO Business Overview
- 4.6.3 CABIO Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CABIO Formula DHA Product Portfolio
- 4.6.5 CABIO Recent Developments
- 4.7 Fuxing
- 4.7.1 Fuxing Company Information
- 4.7.2 Fuxing Business Overview
- 4.7.3 Fuxing Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fuxing Formula DHA Product Portfolio
- 4.7.5 Fuxing Recent Developments
- 4.8 Runke
- 4.8.1 Runke Company Information
- 4.8.2 Runke Business Overview
- 4.8.3 Runke Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Runke Formula DHA Product Portfolio
- 4.8.5 Runke Recent Developments
- 4.9 Cellana
- 4.9.1 Cellana Company Information
- 4.9.2 Cellana Business Overview
- 4.9.3 Cellana Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cellana Formula DHA Product Portfolio
- 4.9.5 Cellana Recent Developments
- 4.10 JC Biotech
- 4.10.1 JC Biotech Company Information
- 4.10.2 JC Biotech Business Overview
- 4.10.3 JC Biotech Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 JC Biotech Formula DHA Product Portfolio
- 4.10.5 JC Biotech Recent Developments
- 4.11 Yuexiang
- 4.11.1 Yuexiang Company Information
- 4.11.2 Yuexiang Business Overview
- 4.11.3 Yuexiang Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yuexiang Formula DHA Product Portfolio
- 4.11.5 Yuexiang Recent Developments
- 4.12 FEMICO
- 4.12.1 FEMICO Company Information
- 4.12.2 FEMICO Business Overview
- 4.12.3 FEMICO Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 FEMICO Formula DHA Product Portfolio
- 4.12.5 FEMICO Recent Developments
- 4.13 Huison
- 4.13.1 Huison Company Information
- 4.13.2 Huison Business Overview
- 4.13.3 Huison Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Huison Formula DHA Product Portfolio
- 4.13.5 Huison Recent Developments
- 4.14 Qingdao Keyuan
- 4.14.1 Qingdao Keyuan Company Information
- 4.14.2 Qingdao Keyuan Business Overview
- 4.14.3 Qingdao Keyuan Formula DHA Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Qingdao Keyuan Formula DHA Product Portfolio
- 4.14.5 Qingdao Keyuan Recent Developments
5 Global Formula DHA Market Scenario by Region
- 5.1 Global Formula DHA Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Formula DHA Sales by Region: 2021-2032
- 5.2.1 Global Formula DHA Sales by Region: 2021-2026
- 5.2.2 Global Formula DHA Sales by Region: 2027-2032
- 5.3 Global Formula DHA Revenue by Region: 2021-2032
- 5.3.1 Global Formula DHA Revenue by Region: 2021-2026
- 5.3.2 Global Formula DHA Revenue by Region: 2027-2032
- 5.4 North America Formula DHA Market Facts & Figures by Country
- 5.4.1 North America Formula DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Formula DHA Sales by Country (2021-2032)
- 5.4.3 North America Formula DHA Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Formula DHA Market Facts & Figures by Country
- 5.5.1 Europe Formula DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Formula DHA Sales by Country (2021-2032)
- 5.5.3 Europe Formula DHA Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Formula DHA Market Facts & Figures by Country
- 5.6.1 Asia Pacific Formula DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Formula DHA Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Formula DHA Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Formula DHA Market Facts & Figures by Country
- 5.7.1 South America Formula DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Formula DHA Sales by Country (2021-2032)
- 5.7.3 South America Formula DHA Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Formula DHA Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Formula DHA Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Formula DHA Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Formula DHA Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Formula DHA Sales by Type (2021-2032)
- 6.1.1 Global Formula DHA Sales by Type (2021-2032) & (t)
- 6.1.2 Global Formula DHA Sales Market Share by Type (2021-2032)
- 6.2 Global Formula DHA Revenue by Type (2021-2032)
- 6.2.1 Global Formula DHA Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Formula DHA Revenue Market Share by Type (2021-2032)
- 6.3 Global Formula DHA Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Formula DHA Sales by Application (2021-2032)
- 7.1.1 Global Formula DHA Sales by Application (2021-2032) & (t)
- 7.1.2 Global Formula DHA Sales Market Share by Application (2021-2032)
- 7.2 Global Formula DHA Revenue by Application (2021-2032)
- 7.2.1 Global Formula DHA Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Formula DHA Revenue Market Share by Application (2021-2032)
- 7.3 Global Formula DHA Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Formula DHA Value Chain Analysis
- 8.1.1 Formula DHA Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Formula DHA Production Mode & Process
- 8.2 Formula DHA Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Formula DHA Distributors
- 8.2.3 Formula DHA Customers
9 Global Formula DHA Analyzing Market Dynamics
- 9.1 Formula DHA Industry Trends
- 9.2 Formula DHA Industry Drivers
- 9.3 Formula DHA Industry Opportunities and Challenges
- 9.4 Formula DHA Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst